Cargando…
Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways
The Chikungunya virus (CHIKV) causes Chikungunya fever, a disease characterized by symptoms such as arthralgia/polyarthralgia. Currently, there are no antivirals approved against CHIKV, emphasizing the need to develop novel therapies. The imidazonaphthyridine compound (RO8191), an interferon-α (IFN-...
Autores principales: | Ruiz, Uriel Enrique Aquino, Santos, Igor Andrade, Grosche, Victória Riquena, Fernandes, Rafaela Sachetto, de Godoy, Andre Schutzer, Torres, Jhoan David Aguillón, Freire, Marjorie Caroline Liberato Cavalcanti, Mesquita, Nathalya Cristina de Moraes Roso, Guevara-Vega, Marco, Nicolau-Junior, Nilson, Sabino-Silva, Robinson, Mineo, Tiago Wilson Patriarca, Oliva, Glaucius, Jardim, Ana Carolina Gomes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194360/ https://www.ncbi.nlm.nih.gov/pubmed/36565816 http://dx.doi.org/10.1016/j.virusres.2022.199029 |
Ejemplares similares
-
Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4
por: Martins, Daniel Oliveira Silva, et al.
Publicado: (2022) -
Antivirals Against Chikungunya Virus: Is the Solution in Nature?
por: Oliveira Silva Martins, Daniel, et al.
Publicado: (2020) -
Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate
por: Freire, Marjorie C. L. C., et al.
Publicado: (2022) -
The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication
por: Policastro, Lucca R., et al.
Publicado: (2022) -
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)